Clinical trial
Radiofrequency Ablation in Treating Patients With Unresectable Primary or…
NCT00019604 · National Institutes of Health Clinical Center (CC), NIH · Terminated
Key facts
| NCT number | NCT00019604 |
|---|---|
| Title | Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer |
| Official title | The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Procedure, Radiation |
| Interventions | computed tomography, magnetic resonance imaging, positron emission tomography, radiofrequency ablation, radionuclide imaging, ultrasound imaging, fludeoxyglucose F 18 (FDG-PET), gadopentetate dimeglumine |
| Enrollment | 44 |
| Start date | Aug 1, 1998 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: